Top

Published in:

01-05-2004

Prior Medical Conditions and Medication use and Risk of non-Hodgkin lymphoma in Connecticut United States Women

Authors: Yawei Zhang, Theodore R. Holford, Brian Leaderer, Shelia Hoar Zahm, Peter Boyle, Lindsay McOmber Morton, Bing Zhang, Kaiyong Zou, Stuart Flynn, Giovanni Tallini, Patricia H. Owens, Tongzhang Zheng

Published in: Cancer Causes & Control | Issue 4/2004

Title: Prior Medical Conditions and Medication use and Risk of non-Hodgkin lymphoma in Connecticut United States Women
Authors: Yawei Zhang
Theodore R. Holford
Brian Leaderer
Shelia Hoar Zahm
Peter Boyle
Lindsay McOmber Morton
Bing Zhang
Kaiyong Zou
Stuart Flynn
Giovanni Tallini
Patricia H. Owens
Tongzhang Zheng
Publication date: 01-05-2004
Publisher: Kluwer Academic Publishers
Published in: Cancer Causes & Control / Issue 4/2004
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI: https://doi.org/10.1023/B:CACO.0000027506.55846.5d

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 4/2004

Residential Traffic Density and Cancer Incidence in Amsterdam, 1989–1997

Reviewers Response

Occupational Exposures, Anatomic Location, and Geographic Distribution of Laryngeal Cancer

Smoking and Cancer Risk in Korean Men and Women

Coffee, Tea and Caffeine and Risk of Epithelial Ovarian Cancer

Smoking and Hodgkin Lymphoma Risk in Women United States

Keynote webinar | Spotlight on antibody–drug conjugates in cancer